FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2621793675> ?p ?o ?g. }

• W2621793675 endingPage "793" @default.
• W2621793675 startingPage "781" @default.
• W2621793675 abstract "New effective treatments are needed to improve outcomes for multiple myeloma (MM) patients. Receptors with restricted expression on plasma cells (PCs) represent attractive new therapeutic targets. The endothelin-1 (EDN1) axis, consisting of EDN1 acting through EDN-receptor A (EDNRA) and B (EDNRB), was previously shown to be overexpressed in several tumours, including MM. However, there is incomplete understanding of how EDN1 axis regulates MM growth and response to therapy. Besides EDNRA, the majority of MM cell lines and primary malignant PCs express high levels of EDNRB and release EDN1. Similarly, bone-marrow microenvironment cells also secrete EDN1. Investigating the extent of epigenetic dysregulation of EDNRB gene in MM, we found that hypermethylation of EDNRB promoter and subsequent down-regulation of EDNRB gene was observed in PCs or B lymphocytes from healthy donors compared to EDNRB-expressing malignant PCs. Pharmacological blockade with the dual EDN1 receptor antagonist bosentan decreased cell viability and MAPK activation of U266 and RPMI-8226 cells. Interestingly, the combination of bosentan and the proteasome inhibitor bortezomib, currently approved for MM treatment, resulted in synergistic cytotoxic effects. Overall, our data has uncovered EDN1-mediated autocrine and paracrine mechanisms that regulate malignant PCs growth and drug response, and support EDN1 receptors as new therapeutic targets in MM." @default.
• W2621793675 created "2017-06-15" @default.
• W2621793675 creator A5008332699 @default.
• W2621793675 creator A5018343914 @default.
• W2621793675 creator A5019259641 @default.
• W2621793675 creator A5020636005 @default.
• W2621793675 creator A5026914836 @default.
• W2621793675 creator A5034067582 @default.
• W2621793675 creator A5036223053 @default.
• W2621793675 creator A5037683977 @default.
• W2621793675 creator A5044025255 @default.
• W2621793675 creator A5045665524 @default.
• W2621793675 creator A5055628496 @default.
• W2621793675 creator A5063509449 @default.
• W2621793675 creator A5065548367 @default.
• W2621793675 creator A5066461145 @default.
• W2621793675 creator A5067105482 @default.
• W2621793675 creator A5076061836 @default.
• W2621793675 creator A5079087703 @default.
• W2621793675 creator A5085292624 @default.
• W2621793675 creator A5090987336 @default.
• W2621793675 date "2017-06-09" @default.
• W2621793675 modified "2023-10-13" @default.
• W2621793675 title "Endothelin-1 receptor blockade as new possible therapeutic approach in multiple myeloma" @default.
• W2621793675 cites W1492199693 @default.
• W2621793675 cites W1511251378 @default.
• W2621793675 cites W1529524149 @default.
• W2621793675 cites W1533086133 @default.
• W2621793675 cites W1546748481 @default.
• W2621793675 cites W1601856726 @default.
• W2621793675 cites W1709326539 @default.
• W2621793675 cites W1777794242 @default.
• W2621793675 cites W1885204825 @default.
• W2621793675 cites W1973932751 @default.
• W2621793675 cites W1980138733 @default.
• W2621793675 cites W1986266121 @default.
• W2621793675 cites W1999018351 @default.
• W2621793675 cites W2006382315 @default.
• W2621793675 cites W2009426416 @default.
• W2621793675 cites W2014053946 @default.
• W2621793675 cites W2014760371 @default.
• W2621793675 cites W2018808479 @default.
• W2621793675 cites W2020359290 @default.
• W2621793675 cites W2031692900 @default.
• W2621793675 cites W2051886811 @default.
• W2621793675 cites W2053786679 @default.
• W2621793675 cites W2061243293 @default.
• W2621793675 cites W2063355387 @default.
• W2621793675 cites W2064520370 @default.
• W2621793675 cites W2082578747 @default.
• W2621793675 cites W2084842992 @default.
• W2621793675 cites W2086557047 @default.
• W2621793675 cites W2111897596 @default.
• W2621793675 cites W2120840499 @default.
• W2621793675 cites W2123238153 @default.
• W2621793675 cites W2127009065 @default.
• W2621793675 cites W2131393466 @default.
• W2621793675 cites W2134823129 @default.
• W2621793675 cites W2144728882 @default.
• W2621793675 cites W2155165473 @default.
• W2621793675 cites W2158926375 @default.
• W2621793675 cites W2197967010 @default.
• W2621793675 cites W2275743218 @default.
• W2621793675 cites W2303423278 @default.
• W2621793675 cites W2397214528 @default.
• W2621793675 cites W2402661058 @default.
• W2621793675 cites W2507448136 @default.
• W2621793675 cites W4210343616 @default.
• W2621793675 cites W4252175385 @default.
• W2621793675 cites W78683901 @default.
• W2621793675 doi "https://doi.org/10.1111/bjh.14771" @default.
• W2621793675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28597546" @default.
• W2621793675 hasPublicationYear "2017" @default.
• W2621793675 type Work @default.
• W2621793675 sameAs 2621793675 @default.
• W2621793675 citedByCount "15" @default.
• W2621793675 countsByYear W26217936752017 @default.
• W2621793675 countsByYear W26217936752018 @default.
• W2621793675 countsByYear W26217936752019 @default.
• W2621793675 countsByYear W26217936752020 @default.
• W2621793675 countsByYear W26217936752021 @default.
• W2621793675 countsByYear W26217936752023 @default.
• W2621793675 crossrefType "journal-article" @default.
• W2621793675 hasAuthorship W2621793675A5008332699 @default.
• W2621793675 hasAuthorship W2621793675A5018343914 @default.
• W2621793675 hasAuthorship W2621793675A5019259641 @default.
• W2621793675 hasAuthorship W2621793675A5020636005 @default.
• W2621793675 hasAuthorship W2621793675A5026914836 @default.
• W2621793675 hasAuthorship W2621793675A5034067582 @default.
• W2621793675 hasAuthorship W2621793675A5036223053 @default.
• W2621793675 hasAuthorship W2621793675A5037683977 @default.
• W2621793675 hasAuthorship W2621793675A5044025255 @default.
• W2621793675 hasAuthorship W2621793675A5045665524 @default.
• W2621793675 hasAuthorship W2621793675A5055628496 @default.
• W2621793675 hasAuthorship W2621793675A5063509449 @default.
• W2621793675 hasAuthorship W2621793675A5065548367 @default.
• W2621793675 hasAuthorship W2621793675A5066461145 @default.
• W2621793675 hasAuthorship W2621793675A5067105482 @default.

• next